# REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions

> **NCT02580955** · PHASE3 · UNKNOWN · sponsor: **Flanders Medical Research Program** · enrollment: 120 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** LEGFLOW DCB

## Key facts

- **NCT ID:** NCT02580955
- **Lead sponsor:** Flanders Medical Research Program
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02580955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02580955, "REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02580955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*